1403660-75-2

Upstream product

• 238757-51-2 (1S,5R,6S,7S,8S)-7-Benzyloxy-6,8-dimethyl-2,9-dioxa-bicyclo[3.3.1]nonan-3-one 
• 477781-62-7 (3R,4S,5R,6R)-5-(benzyloxy)-4,6-dimethylheptane-1,3,7-triol 
• 477781-63-8 (2R,3R,4S)-3-(benzyloxy)-4-((R)-2,2-dimethyl-1,3-dioxan-4-yl)-2-methylpentan-1-ol 
• 1403660-65-0 (2R,3R,4S)-3-(benzyloxy)-4-((R)-2,2-dimethyl-1,3-dioxan-4-yl)-2-methylpentyl pivalate 

Downstream Products

• 1403660-66-1 (2R,3R,4S,5R)-3-(benzyloxy)-7-(tert-butyldimethylsilyloxy)-5-hydroxy-2,4-dimethylheptyl pivalate 
• 1403660-73-0 ethyl 2-((R,4E,6E)-N-(2,4-dimethoxybenzyl)-6-methyl-3-oxo-8-((1R,3R,4S,5R)-1,4,8-tri-methyl-2,9-dioxabicyclo[3.3.1]non-7-en-3-yl)nona-4,6-dienamido)acetate 

Relevant academic research and scientific papers

Total synthesis of (?)-tirandamycin c utilizing a desymmetrization protocol

A highly stereoselective total synthesis of (?)-tirandamycin C has been achieved following a desymmetrization protocol developed in our group, Horner-Wadsworth-Emmons olefination, acid-catalyzed ketalization, Still-Gennari (Z)-selective olefination, and D